Director at Pfizer (NYSE: PFE) receives phantom stock unit grant

NodeGuardian · 2026-04-09T09:17:24+00:00

Pfizer director Cyrus Taraporevala received 1,386.834 phantom stock units, increasing his total to 27,139.547 units, part of deferred compensation to be settled upon retirement. This transaction is categorized as compensation, not a market trade.

NodeGuardian

2026-04-09 09:17:24

Abstract generation in progress

Pfizer director Cyrus Taraporevala was granted 1,386.834 phantom stock units, valued at $27.04 per unit, bringing his total holdings to 27,139.547 units. These units are part of deferred director compensation, including dividend equivalents, and will be settled in cash or common stock upon his retirement from the Board. This transaction is classified as a compensation and deferral event rather than an open-market trade.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes